Prophylactic antibiotics are effective in reducing the rate of surgical site infection (SSI). Cephalosporin antibiotics are recommended except for patients colonised with meticillin resistant staphylococcus aureus (MRSA), where glycopeptide antibiotics are indicated. However, in the trauma setting, the MRSA status is unknown prior to surgery.
Aim: To determine if the incidence of MRSA colonisation in trauma patients from long term care (LTC) warrants the use of empirical glycopeptide antibiotics.
Methods: A retrospective analysis of patients admitted with hip fractures was performed. The MRSA status of patient from LTC facilities and home was determined.
Results: The prevalence of MRSA colonisation in patients admitted from LTC facilities was 33.6%, compared to 3.6% for patients admitted from home, P < 0.001.
Our results suggest that risk of patients carrying MRSA is significantly higher for patients being admitted form LTC. This group of patients may benefit from empirical glycopeptide antibiotic when the MRSA status is unknown.
Get full access to this article
View all access options for this article.
References
1.
Boxma H., Broekhuizen T., Patka P., Oosting H. ( 1996) Randomised controlled trial of single-dose antibiotic prophylaxis in surgical treatment of closed fractures: the Dutch Trauma Trial . Lancet347: 1133-7.
2.
Bradley SF, Terpenning MS, Ramsey MA, Zarins LT, Jorgensen KASottile WS, Schaberg DR, Kauffman CA ( 1991) Methicillin-resistant Staphylococcus aureus: colonization and infection in a long-term care facility. Annals of Internal Medicine115: 417-22.
3.
Dancer SJ ( 2008) The effect of antibiotics on methicillin-resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy61: 246-53.
4.
Engemann JJ, Carmeli Y., Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, Briggs JP, Sexton DJ, Kaye KS ( 2003) Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clinical Infectious Diseases36: 592-8.
5.
Furuno JP, Hebden JN, Standiford HC, Perencevich EN, Miller RR, Moore AC, Strauss SM, Harris AD ( 2008) Prevalence of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii in a long-term acute care facility. American Journal of Infection Control36: 468-71.
6.
Gillespie WJ, Walenkamp G. ( 2001) Antibiotic prophylaxis for surgery for proximal femoral and other closed long bone fractures. Cochrane Database System ReviewCD000244.
7.
Haley RW, Culver DH, White JW, Morgan WM, Emori TG ( 1985) The nationwide nosocomial infection rate. A new need for vital statistics. American Journal of Epidemiology, 121: 159-67.
8.
Kachroo S., Dao T., Zabaneh F., Reiter M., Larocco MT, Gentry LO, Garey KW ( 2006) Tolerance of vancomycin for surgical prophylaxis in patients undergoing cardiac surgery and incidence of vancomycin-resistant enterococcus colonization. Annals of Pharmacotherapy40: 381-5.
9.
Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ ( 1999) The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infection Control and Hospital Epidemiology20: 725-30.
10.
Lord SR, Sambrook PN, Gilbert C., Kelly PJ, Nguyen T., Webster IW, E isman JA ( 1994) Postural stability, falls and fractures in the elderly: results from the Dubbo Osteoporosis Epidemiology Study. Medical Journal of Australia160: 684-5, 688-91.
11.
Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR ( 1999) Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infection Control and Hospital Epidemiology20: 250-78; quiz 279-80.
12.
Marcotte AL, Trzeciak, M.A. ( 2008) Community-acquired methicillin-resistant Staphylococcus aureus: an emerging pathogen in orthopaedics. Journal of the American Academy of Orthopaedic Surgeons16:98-106.
13.
Martone WJ, Gaynes RP, Horan TC, Danzig L., Emori TG, Monnet D., Stroud LA, Wright GC, Culver DH, Banerjee SN, et al. (1995) National Nosocomial Infections Surveillance (NNIS) semiannual report, May 1995. A report from the National Nosocomial Infections Surveillance (NNIS) System. American Journal of Infection Control23: 377-85.
14.
Menichetti F., Martino P., Bucaneve G., Gentile G., D'antonio D., Liso V., Ricci P., Nosari AM, Buelli M., Carotenuto M., et al. (1994) Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program. Antimicrobial Agents Chemotherapy38: 2041-6.
15.
Merrer J., Desbouchages L., Serazin V., Razafimamonjy J., Pauthier F., Leneveu M. ( 2006) Comparison of routine prophylaxis with vancomycin or cefazolin for femoral neck fracture surgery: microbiological and clinical outcomes. Infection Control and Hospital Epidemiology27: 1366-71.
16.
Millar BC, Prendergast BD, Moore JE ( 2008) Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis. Journal of Antimicrobial Chemotherapy61: 1-7.
17.
Murphy S., Denman S., Bennett RG, Greenough 3rd, WB, Lindsay J., Zelesnick LB ( 1992) Methicillin-resistant Staphylococcus aureus colonization in a long-term-care facility. Journal of the American Geriatrics Society40: 213-7.
18.
Nixon M., Jackson B., Varghese P., Jenkins D., Taylor G. ( 2006) Methicillin-resistant Staphylococcus aureus on orthopaedic wards: incidence, spread, mortality, cost and control. Journal of Bone and Joint Surgery (Br)88: 812-17.
19.
Pavel A., Smith RL, Ballard A., Larsen IJ ( 1974) Prophylactic antibiotics in clean orthopaedic surgery . Journal of Bone and Joint Surgery (Am)56: 777-82.
20.
Pillar CM, Aranza MK, Shah D., Sahm DF ( 2008) In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-positive and gram-negative isolates of European origin. Journal of Antimicrobial Chemotherapy61: 595-602.
21.
Pr okuski L. ( 2008) Prophylactic antibiotics in orthopaedic surgery. Journal of the American Academy of Orthopaedic Surgery16: 283-93.
Rosina R., Villa G., Danese A., Cavenaghi L., Picardi L., Salvadeo A. ( 1988) Pharmacokinetics of teicoplanin in the elderly. Journal of Antimicrobial Chemotherapy21(Suppl A): 39-45.
24.
Rybak MJ, Cappelletty DM, Moldovan T., Aeschlimann JR, Kaatz GW ( 1998) Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Enterococcus faecium. Antimicrobial Agents Chemotherapy42: 721- 4.
25.
Sanderson PJ ( 2001) The role of methicillin-resistant Staphylococcus aureus in orthopaedic implant surgery. Journal of Chemotherapy13(Spec No 1): 89-95.
26.
Shukla S., Nixon M., Acharya M., Korim MT, Pandey R.(2009) I ncidence of MRSA surgical-site infection in MRSA carriers in an orthopaedic trauma unit. Journal of Bone and Joint Surgery (Br)91: 225-8.
27.
Sivagnanam S., Deleu D. ( 2003) Red man syndrome. Critical Care7: 119- 20.
28.
Soriano, A., Popescu, D., Garcia, S., Bori, G., Martinez, J.A., Balasso, V., Marco, F., Almela, M., Mensa, J. ( 2006) Usefulness of teicoplanin for preventing methicillin-resistant Staphylococcus aureus infections in orthopedic surgery. European Journal of Clinical Microbiology & Infectious Diseases25: 35-8.
Whitehouse JD, Friedman ND, Kirkland KB, Richardson WJ, Sexton DJ ( 2002) The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infection Control and Hospital Epidemiology23: 183-9.
